Branch retinal vein occlusion: Pathogenesis, visual prognosis, and treatment modalities

392Citations
Citations of this article
176Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

In branch retinal vein occlusion (BRVO), abnormal arteriovenous crossing with vein compression, degenerative changes of the vessel wall and abnormal hematological factors constitute the primary mechanism of vessel occlusion. In general, BRVO has a good prognosis: 50-60% of eyes are reported to have a final visual acuity (VA) of 20/40 or better even without treatment. One important prognostic factor for final VA appears to be the initial VA. Grid laser photocoagulation is an established treatment for macular edema in a particular group of patients with BRVO, while promising results for this condition are shown by intravitreal application of steroids or new vascular endothelial growth factor inhibitors. Vitrectomy with or without arteriovenous sheathotomy combined with removal of the internal limiting membrane may improve vision in eyes with macular edema which are unresponsive to or ineligible for laser treatment. Copyright © Informa Healthcare USA, Inc.

Cite

CITATION STYLE

APA

Rehak, J., & Rehak, M. (2008, February). Branch retinal vein occlusion: Pathogenesis, visual prognosis, and treatment modalities. Current Eye Research. https://doi.org/10.1080/02713680701851902

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free